ArticleClinicoEconomics and outcomes research : CEOR2016

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain.

Luis Felipe Casado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.